Hydrochloric Acid → HCID 21701343, compound
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:14]2[CH:15]=[CH:16][CH:17]=[C:18]([CH3:19])[C:13]=2[N:12]([CH2:20][C:21]([C:23]([CH3:26])([CH3:25])[CH3:24])=[O:22])[C:11](=[O:27])[CH:10]([NH:28]C(OC(C)(C)C)=O)[N:9]=1.Cl.C(=O)(O)[O-].[Na+]>C(OCC)(=O)C>[NH2:28][CH:10]1[N:9]=[C:8]([C:3]2[CH:4]=[CH:5][CH:6]=[CH:7][C:2]=2[F:1])[C:14]2[CH:15]=[CH:16][CH:17]=[C:18]([CH3:19])[C:13]=2[N:12]([CH2:20][C:21]([C:23]([CH3:25])([CH3:24])[CH3:26])=[O:22])[C:11]1=[O:27]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 0 °C
Procedure
A mixture of (3RS)-2,3-dihydro-5-(2-fluorophenyl)-1-tert-butylcarbonylmethyl-3-tert-butoxycarbonylamino-9-methyl-1H-1,4-benzodiazepin-2-one (130 mg) and 4N HCl in ethyl acetate (1 ml) was stirred at 0° C. for 5 hours. Ethyl acetate and a saturated aqueous solution of sodium bicarbonate were added to the reaction mixture. The separated organic layer was washed with water and brine, and then dried over sodium sulfate. The solvent was evaporated in vacuo to afford (3RS)-3-amino-2,3-dihydro-5-(2-fluorophenyl)-1-tert-butylcarbonylmethyl-9-methyl-1H-1,4-benzodiazepin-2-one (100 mg, 97.1%) as a crystalline powder.
Workup
- washThe separated organic layer was washed with water and brine
- dry with materialdried over sodium sulfate
- customThe solvent was evaporated in vacuo
Sources & evidence
- ORD record
- ord-8ee733e095ec412db0646a6db6ada886
- Source dataset
- uspto-grants-2001_09
- Patent number
- US06291452B1
Reaction notes
Loading…